DrugDashboards

Lbel Solutions Pro-Hialuron Base Serum Con Efecto Relleno De Arrugas Fps 15 Wrinkle Filler Effect Serum Foundation Spf 15 Latte 180-F

Octinoxate, Zinc Oxide · ZINC OXIDE 29.4 mg/mL; OCTINOXATE 45 mg/mL · Liquid · Topical · Bel Star S.a.

NDC 14141-0334-01 · 1 BOTTLE, GLASS in 1 BOX / 30 mL in 1 BOTTLE, GLASS · OTC MONOGRAPH DRUG · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
M020
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Octinoxate, Zinc Oxide (Liquid)

LabelerStrengthFirst seenLast seen
Bel Star S.a.ZINC OXIDE 29.4 mg/mL; OCTINOXATE 45 mg/mLAug 26, 2026Sep 3, 2026
Distribuidora Comercial Jafra, S.A. de C.V.OCTINOXATE 3 g/100mL; ZINC OXIDE 6.8 g/100mLJul 15, 2026Sep 3, 2026
Bel Star S.a.ZINC OXIDE 45 mg/mL; OCTINOXATE 29.4 mg/mLJul 22, 2026Aug 22, 2026
Bel Star S.a.OCTINOXATE 45 mg/mL; ZINC OXIDE 29.4 mg/mLJul 15, 2026Jul 18, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lbel Solutions Pro-Hialuron Base Serum Con Efecto Relleno De Arrugas Fps 15 Wrinkle Filler Effect Serum Foundation Spf 15 Latte 180-F — NDC 14141-0334-01," retrieved September 3, 2026, https://drugdashboards.com/drug/14141033401.

Free to cite with attribution — see how the data is put together.